Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology, molecular docking and...

por Yang, Rong, Yang, Huili, Jiang, Dansheng, Xu, Linyi, Feng, Lian, Xing, Yufeng
Publicado 2022

Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis

por Yang, Huili, Feng, Lian, Xu, Linyi, Jiang, Dansheng, Zhai, Fenfen, Tong, Guangdong, Xing, Yufeng
Publicado 2022

Efficacy and safety of acetyl-CoA carboxylase (ACC) inhibitors in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review

por Xu, Liubin, Yang, Huili, Xu, Hongling, Yang, Rong, Fen, Lian, Jiang, Dansheng, Xu, Linyi, Xing, Yufeng
Publicado 2022